Taiwanese Journal of Obstetrics and Gynecology
Volume 44, Issue 2 , Pages 116-122 , June 2005

Cell-Free Fetal DNA in Plasma of Pregnant Women: Clinical Potential and Origin

  • Akihiko Sekizawa

      Affiliations

    • Corresponding Author InformationCorrespondence to: Dr. Akihiko Sekizawa, Department of Obstetrics and Gynecology, Showa University School of Medicine, 1-5-8, Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan
    • ,
  • Antonio Farina
    • ,
  • Takashi Okai

Received 17 January 2005 ,Revised 26 January 2005 ,Accepted 26 January 2005.

References 

  1. Teshima IE , Kalousek DK , Vekemans MJ , et al.   Canadian multicenter randomized clinical trial of chorion villus sampling and amniocentesis. chromosome mosaicism in CVS and amniocentesis samples . Prenat Diagn . 1992;12:443–466
  2. Bianchi DW , Zickwolf GK , Weil GJ , Sylvester S , DeMaria MA . Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum . Proc Natl Acad Sci USA . 1996;93:705–708
  3. DeMaria MA , Zheng YL , Zhen D , Weinschenk NM , Vadnais TJ , Bianchi DW . Improved fetal nucleated erythrocyte sorting purity using intracellular antifetal hemoglobin and Hoechst 33342 . Cytometry . 1996;25:37–45
  4. Sekizawa A , Samura O , Zhen DK , Falco V , Bianchi DW . Fetal cell recycling: diagnosis of gender and RhD genotype in the same fetal cell retrieved from maternal blood . Am J Obstet Gynecol . 1999;181:1237–1242
  5. Ganshirt D , Borjesson-Stoll R , Burschyk M , et al.   Successful prenatal diagnosis from maternal blood with magnetic-activated cell sorting . Ann NY Acad Sci . 1994;731:103–114
  6. Kitagawa M , Sugiura K , Omi H , et al.   New technique using galactose-specific lectin for isolation of fetal cells from maternal blood . Prenat Diagn . 2002;22:17–21
  7. Takabayashi H , Kuwabara S , Ukita T , Ikawa K , Yamafuji K , Igarashi T . Development of non-invasive fetal DNA diagnosis from maternal blood . Prenat Diagn . 1995;15:74–77
  8. Sekizawa A , Kimura T , Sasaki M , Nakamura S , Kobayashi R , Sato T . Prenatal diagnosis of Duchenne muscular dystrophy using a single fetal nucleated erythrocyte in maternal blood . Neurology . 1996;46:1350–1353
  9. Bianchi DW , Williams JM , Sullivan LM , Hanson FW , Klinger KW , Shuber AP . PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies . Am J Hum Genet . 1997;61:822–829
  10. Bianchi DW , Simpson JL , Jackson LG , et al.   Fetal cells in maternal blood: NIFTY clinical trial interim analysis. DMSTAT. NICHD fetal cell study (NIFTY) group . Prenat Diagn . 1999;19:994–995
  11. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum . Lancet . 1997;350:485–487
  12. Lo YM , Tein MS , Lau TK , et al.   Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis . Am J Hum Genet . 1998;62:768–775
  13. Sekizawa A, Kondo T, Iwasaki M, Watanabe A, Jimbo M, Saito H, et al. Accuracy of fetal gender determination by analysis of DNA in maternal plasma . Clin Chem . 2001;47:1856–1858
  14. Lo YM , Zhang J , Leung TN , Lau TK , Chang AM , Hjelm NM . Rapid clearance of fetal DNA from maternal plasma . Am J Hum Genet . 1999;64:218–224
  15. Lo YM , Hjelm NM , Fidler C , et al.   Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma . N Engl J Med . 1998;339:1734–1738
  16. Saito H , Sekizawa A , Morimoto T , Suzuki M , Yanaihara T . Prenatal DNA diagnosis of a single-gene disorder from maternal plasma . Lancet . 2000;356:1170
  17. Shiang R , Thompson LM , Zhu YZ , et al.   Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia . Cell . 1994;78:335–342
  18. Amicucci P , Gennarelli M , Novelli G , Dallapiccola B . Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma . Clin Chem . 2000;46:301–302
  19. Gonzalez-Gonzalez MC , Garcia-Hoyos M , Trujillo MJ , et al.   Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma . Prenat Diagn . 2002;22:946–948
  20. Chiu RW , Lau TK , Leung TN , Chow KC , Chui DH , Lo YM . Prenatal exclusion of beta thalassaemia major by examination of maternal plasma . Lancet . 2002;360:998–1000
  21. Chiu RW , Lau TK , Cheung PT , Gong ZQ , Leung TN , Lo YM . Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study . Clin Chem . 2002;48:778–780
  22. Lo YM , Leung TN , Tein MS , et al.   Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia . Clin Chem . 1999;45:184–188
  23. Zhong XY , Holzgreve W , Hahn S . Circulatory fetal and maternal DNA in pregnancies at risk and those affected by preeclampsia . Ann NY Acad Sci . 2001;945:138–140
  24. Sekizawa A, Jimbo M, Saito H, Iwasaki M, Matsuoka R, Okai T, et al. Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction . Am J Obstet Gynecol . 2003;188:480–484
  25. Caramelli E , Rizzo N , Concu M , et al.   Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction – a pilot study . Prenat Diagn . 2003;23:367–371
  26. Roberts JM , Cooper DW . Pathogenesis and genetics of preeclampsia . Lancet . 2001;357:53–56
  27. Sekizawa A , Yokokawa K , Sugito Y , et al.   Evaluation of bidirectional transfer of plasma DNA through placenta . Hum Genet . 2003;113:307–310
  28. Sekizawa A , Farina A , Koide K , et al.   Beta-globin DNA in maternal plasma as a molecular marker of preeclampsia . Prenat Diagn . 2004;24:697–700
  29. Leung TN , Zhang J , Lau TK , Chan LY , Lo YM . Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia . Clin Chem . 2001;47:137–139
  30. Farina A , Sekizawa A , Iwasaki M , Matsuoka R , Ichizuka K , Okai T . Total cell-free DNA (beta-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening . Prenat Diagn . 2004;24:722–726
  31. Sekizawa A , Sugito Y , Iwasaki M , et al.   Cell-free fetal DNA is increased in plasma of women with hyperemesis gravidarum . Clin Chem . 2001;47:2164–2165
  32. Sugito Y , Sekizawa A , Farina A , et al.   Relationship between severity of hyperemesis gravidarum and fetal DNA concentration in maternal plasma . Clin Chem . 2003;49:1667–1669
  33. Minagawa M , Narita J , Tada T , et al.   Mechanisms underlying immunologic states during pregnancy: possible association of the sympathetic nervous system . Cell Immunol . 1999;196:1–13
  34. Sekizawa A , Jimbo M , Saito H , et al.   Increased cell-free fetal DNA in plasma of two women with invasive placenta . Clin Chem . 2002;48:353–354
  35. Jimbo M, Sekizawa A, Sugito Y, Matsuoka R, Ichizuka K, Saito H, et al. Placenta increta: postpartum monitoring of plasma cell-free fetal DNA . Clin Chem . 2003;49:1540–1541
  36. Leung TN , Zhang J , Lau TK , Hjelm NM , Lo YM . Maternal plasma fetal DNA as a marker for preterm labour . Lancet . 1998;352:1904–1905
  37. Farina A, LeShane E, Romero R, Gomez R, Chaiworapongsa T, Rizzo N, et al. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery . Am J Obstet Gynecol . 2005; [In press]
  38. Lo YM , Lau TK , Zhang J , et al.   Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21 . Clin Chem . 1999;45:1747–1751
  39. Zhong XY , Burk MR , Troeger C , Jackson LR , Holzgreve W , Hahn S . Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses . Prenat Diagn . 2000;20:795–798
  40. Farina A , LeShane ES , Lambert-Messerlian GM , et al.   Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy . Clin Chem . 2003;49:239–242
  41. Ohashi Y , Miharu N , Honda H , Samura O , Ohama K . Quantitation of fetal DNA in maternal serum in normal and aneuploid pregnancies . Hum Genet . 2000;108:123–127
  42. Sekizawa A , Samura O , Zhen DK , Falco V , Farina A , Bianchi DW . Apoptosis in fetal nucleated erythrocytes circulating in maternal blood . Prenat Diagn . 2000;20:886–889
  43. Kondo T , Sekizawa A , Saito H , Jimbo M , Sugito Y , Okai T . Fate of fetal nucleated erythrocytes circulating in maternal blood: apoptosis is induced by maternal oxygen concentration . Clin Chem . 2002;48:1618–1620
  44. Angert RM , LeShane ES , Lo YM , Chan LY , Delli-Bovi LC , Bianchi DW . Fetal cell-free plasma DNA concentrations in maternal blood are stable 24 hours after collection: analysis of first- and third-trimester samples . Clin Chem . 2003;49:195–198
  45. Al-Mufti R , Lees C , Albaiges G , Hambley H , Nicolaides KH . Fetal cells in maternal blood of pregnancies with severe fetal growth restriction . Hum Reprod . 2000;15:218–221
  46. Hoesli I , Danek M , Lin D , Li Y , Hahn S , Holzgreve W . Circulating erythroblasts in maternal blood are not elevated before onset of preterm labor . Obstet Gynecol . 2002;100:992–996
  47. Loke YW , King A . Immunology of human placental implantation: clinical implications of our current understanding . Mol Med Today . 1997;3:153–159
  48. Ishihara N , Matsuo H , Murakoshi H , Laoag-Fernandez JB , Samoto T , Maruo T . Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation . Am J Obstet Gynecol . 2002;186:158–166

PII: S1028-4559(09)60122-4

doi: 10.1016/S1028-4559(09)60122-4

Taiwanese Journal of Obstetrics and Gynecology
Volume 44, Issue 2 , Pages 116-122 , June 2005

Article Tools